NB Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
22
- Portfolio
-
3
- Exits
-
12
NB Capital General Information
Description
Founded in 2001, NB Capital is an investment firm based in Copenhagen, Denmark. The firm prefers to invest in the healthcare sector with a particular focus on all phases of pharmaceutical drug development and commercial enterprises.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
Danish Venture Capital Association (DAVCA)
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
- Østergade 24A, 1
- 3rd floor
- 1100 Copenhagen
- Denmark
NB Capital Investments (22)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Almirall | 12-Nov-2019 | Secondary Transaction - Private | 00000 | Pharmaceuticals | Generating Revenue/Not Profitable | |
| 0000000000 | 01-Nov-2019 | 00000 00000 | 00000 | Human Capital Services | Generating Revenue | |
| 000000000 | 26-Mar-2018 | 0000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | |
| 000000 00000000000 | 28-Feb-2008 | 00000 00000 | 000 | Drug Discovery | Out of Business | 0000000 000000000000 |
| 0000 000000 | 11-Feb-2008 | 00000 00000 | 000 | Drug Discovery | Generating Revenue | |
| 0000000000 0000000 | 07-Jul-2007 | 00000 00000 | 00.000 | Pharmaceuticals | Generating Revenue | 0000000 000000000000 |
| 0000000 000000 | 19-Jun-2006 | 00000 00000 | Biotechnology | Profitable | ||
| 0000000000 0000000 | 24-May-2006 | 00000 00000 | 0000 | Pharmaceuticals | Generating Revenue | 0000000 000000000000 |
| Rose Pharma | 07-Dec-2005 | Later Stage VC | 00.000 | Drug Discovery | Generating Revenue | |
| Aditech Pharma | 01-Jun-2005 | Buyout/LBO | Other Commercial Services | Out of Business |
NB Capital Exits (12)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Arriva Pharmaceuticals | 30-Apr-2021 | Out of Business | |
| 0000 000000 | 01-Feb-2021 | 000000000 00000000 | |
| 00000000000 | 17-Dec-2015 | 000 | 0000 |
| 0000000 0000000000 | 11-Mar-2013 | 000000000000000000 | |
| 0000000 000000 | 01-Feb-2011 | 0000000000: 000000 | |
| 000000000 | 27-Apr-2009 | 0000000000: 000000 | |
| 0000000 0000000000 | 13-Nov-2006 | 000 | |
| 0000 000000 | 28-Oct-2005 | 000000000000000000 | 000.00 |
| Poalis | 02-Sep-2005 | Merger/Acquisition | |
| PDL Biopharma | 18-Mar-1997 | IPO | 000.00 |
NB Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
NB Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
NB Capital Team (5)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Florian Schonharting | Co-Founder & Chief Executive Officer | 0 | 0 | Copenhagen, Denmark | |
| Cora Madsen | Director | Copenhagen, Denmark | |||
| Christian Karsten Hansen Ph.D | Co-Founder & Co-Owner | 0 | 0 | Copenhagen, Denmark | |
| Magnus Halle | Analyst | Copenhagen, Denmark |
NB Capital Co-Investors (8)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| 42K Investimentos | 1 |
|
|
||
| Barrah Investimentos | 0 |
|
|
||
| Bossanova Investimentos | 0 |
|
|
||
| Gávea Angel Group | 0 | 0 |
|
|
|
| Hangar8 | 0 |
|
|